Effects of DNA dose, route of vaccination, and coadministration of porcine interleukin-6 DNA on results of DNA vaccination against influenza virus infection in pigs

American Journal of Veterinary Research

Volumn 63, Issue 5, 2002, Pages 653-659

  Larsen, Diane L ^a   Olsen, Christopher W ^a  

^a UNIVERSITY OF WISCONSIN MADISON   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADJUVANT; DNA VACCINE; INFLUENZA VIRUS HEMAGGLUTININ; INTERLEUKIN 6; VIRUS ANTIBODY;

ANIMAL EXPERIMENT; ANTIBODY DETECTION; ARTICLE; CONTROLLED STUDY; DOSE RESPONSE; DRUG EFFECT; GENE DELIVERY SYSTEM; GENE GUN; HUMORAL IMMUNITY; IMMUNE RESPONSE; IMMUNITY; INFLUENZA; INFLUENZA VIRUS; NONHUMAN; NOSE MUCOSA; NOSE SECRETION; NUCLEOTIDE SEQUENCE; PROVOCATION TEST; SWINE DISEASE; VACCINATION; VIRUS SHEDDING;

ANIMALIA; INFLUENZA VIRUS; SUIDAE; SUS SCROFA; SWINE INFLUENZA VIRUS;

EID: 0036256807     PISSN: 00029645     EISSN: None     Source Type: Journal    
DOI: 10.2460/ajvr.2002.63.653     Document Type: Article

References (55)

1. Swine influenza
2. Virologic and serologic surveillance for human, swine and avian influenza virus infections among pigs in the north-central United States
3. The emergence of novel swine influenza viruses in North America
4. Classic swine influenza
5. Effect of sequential porcine reproductive and respiratory syndrome and swine influenza on the growth and performance of finishing pigs
6. Dual infections of feeder pigs with porcine reproductive and respiratory syndrome virus followed by porcine respiratory coronavirus or swine influenza virus: A clinical and virological study
7. Evolution and ecology of influenza A viruses
8. Molecular basis for the generation in pigs of influenza A viruses with pandemic potential
9. The nucleoprotein as a possible major factor in determining host specificity of influenza H3N2 viruses
10. Fish farming and influenza pandemics
11. Systemic and mucosal immune responses to H1N1 influenza virus infection in pigs
12. MaxiVac-FLU: Evaluation of the safety and efficacy of a swine influenza vaccine
13. Immunization of pigs with a particle-mediated DNA vaccine to influenza A protects against challenge with homologous virus
14. Molecular medicine-DNA vaccines
15. Particle-mediated nucleic acid immunization
16. DNA vaccines
17. DNA vaccines
18. Immunization of animals: From DNA to the dinner plate
19. Immunization of dogs and cats with a DNA vaccine against rabies virus
20. Nucleic acid immunization protects dogs against challenge with virulent canine parvovirus
21. DNA vaccines: Protective immunizations by parenteral, mucosal, and gene-gun inoculations
22. Protective immunity by intramuscular injection of low doses of influenza virus DNA vaccines
23. Further protection against antigenic drift of influenza virus in a ferret model by DNA vaccination
24. Antibody-forming cell response to virus challenge in mice immunized with DNA encoding the influenza virus hemagglutinin
25. Characterization of humoral immune responses induced by an influenza hemagglutinin DNA vaccine
26. Coadministration of DNA encoding interleukin-6 and hemagglutinin confers protection from influenza virus challenge in mice
27. Intradermal DNA immunization by using jet-injectors in mice and monkeys
28. Antibody responses to DNA vaccination of horses using the influenza virus hemagglutinin gene
29. IL-6 induces long-term protective immunity against a lethal challenge of influenza virus
30. DNA vaccination against influenza viruses: A review with emphasis on equine and swine influenza
31. Protection and antibody responses in different strains of mouse immunized with plasmid DNAs encoding influenza virus haemagglutinin, neuraminidase and nucleoprotein
32. Potential advantages of DNA immunization for influenza epidemic and pandemic planning
33. DNA vaccines: A novel approach to immunization
34. Gene gun-based nucleic acid immunization: Elicitation of humoral and cytotoxic T lymphocyte responses following epidermal delivery of nanogram quantities of DNA
35. Mucosal vaccines for the prevention of influenza
36. Mucosal immunization with DNA encoding influenza hemagglutinin
37. Mucosal immunization with DNA-liposome complexes
38. In vivo adjuvant effect of interleukins 5 and 6 on rat tear IgA antibody responses
39. The role of interleukin-6 in mucosal IgA antibody responses in vivo
40. Manipulation of the immune response to a plasmid-encoded viral antigen by co-inoculation with plasmids expressing cytokines
41. DNA vaccines: Immunology, application, and optimization
42. Interleukin-6: An overview
43. Mucosal immunity: Implications for vaccine development
44. Genetically engineered vaccines
45. Dose response of A/Alaska/6/77 (H3N2) cold-adapted reassortant vaccine virus in adult volunteers: Role of local antibody in resistance to infection with vaccine virus
46. Cross-protection in mice infected with influenza A virus by the respiratory route is correlated with local IgA antibody rather than serum antibody or cytotoxic T cell reactivity
47. Functional role of respiratory tract haemagglutinin-specific IgA antibodies in protection against influenza
48. Immunoglobulin A mediation of murine nasal anti-influenza virus immunity
49. Immunogenicity and efficacy of baculovirus-expressed and DNA-based equine influenza virus hemagglutinin vaccines in mice
50. Regulation of interleukin-6 expression in porcine immune cells
51. Antigenic and genetic analysis of a recently isolated H1N1 swine influenza virus
52. Concepts and procedures for laboratory-based influenza surveillance
53. Simple method of estimating 50 percent endpoints
54. DNA vaccination favors memory rather than effector B cell responses
55. Immunization of pigs against influenza virus infection by DNA vaccine priming followed by killed-virus vaccine boosting